Indian Army Cardiovascular Drug Procurement for Military Healthcare

This tender, issued by the Department of Military Affairs, Ministry of Defence, under Bid Number GEM/2026/B/8137290, represents a critical procurement opportunity for essential pharmaceutical supplies by the Indian Army. Commencing on October 22, 2026, at 11:19 AM and concluding on November 5, 2026, at 12:00 PM, this tender solicits bids for a comprehensive list of Cardiovascular Drugs (CDL DRUGS) with a total quantity of 1,918,740 units. The specific items required include a wide range of Olmesartan formulations (20mg, 40mg, with and without Hydrochlorothiazide), Perindopril (4mg, 8mg), Prazosin (5mg sustained release), Ramipril (10mg, 5mg with Hydrochlorothiazide), Sildenafil Citrate (50mg), Telmisartan (40mg with Amlodipine 5mg, and 40mg alone), Torsemide (100mg, 20mg, 5mg with Spironolactone 25mg, and 5mg alone), Verapamil (120mg sustained release), Flecainide (50mg), Carvedilol (12.5mg, 6.25mg), and Eplerenone (50mg, 25mg). This procurement is vital for the ongoing healthcare needs of military personnel and underscores the importance of reliable and high-quality pharmaceutical suppliers.